"UPMC St. Margaret is a hospital located in Pittsburgh.Visit our website to learn more about the conditions we treat and the services we offer. Schedule your appointment today. UPMC is committed to protecting our communities from the spread of COVID-19. We continue to require people who come to any UPMC facility to wear a facemask that covers their nose and mouth and to practice other preventative efforts like social distancing, even if fully vaccinated."

During the past decade, UPMC-Saint Margaret conducted 64 clinical trials. In the 10-year time frame, 64 clinical trials started and 36 clinical trials were completed, i.e. on average, 56.3% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 35 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UPMC-Saint Margaret" #1 sponsor was "National Cancer Institute (NCI)" with 35 trials, followed by "Alliance for Clinical Trials in Oncology" with 15 trials sponsored, "SWOG Cancer Research Network" with 15 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored and "NRG Oncology" with 7 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC-Saint Margaret" #1 collaborator was "National Cancer Institute (NCI)" with 50 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Radiation Therapy Oncology Group" with 2 trials as a collaborator and "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "UPMC-Saint Margaret" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Breast Cancer" (6 trials), "Stage II Breast Cancer" (6 trials) and "Stage IIIA Breast Cancer" (6 trials). Many other conditions were trialed in "UPMC-Saint Margaret" in a lesser frequency.

Most popular intervention types in "UPMC-Saint Margaret" are "Drug" (72 trials), "Other" (54 trials), "Biological" (32 trials), "Radiation" (28 trials) and "Procedure" (25 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (32 trials), "Quality-of-Life Assessment" (19 trials), "Cisplatin" (15 trials), "Docetaxel" (12 trials) and "Carboplatin" (11 trials). Other intervention names were less common.

The vast majority of trials in "UPMC-Saint Margaret" are 78 trials for "All" genders, 15 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "UPMC-Saint Margaret". undefined are not yet recruiting, 25 are recruiting, 44 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in UPMC-Saint Margaret, 3 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in UPMC-Saint Margaret, 1 "Phase 1" clinical trials were conducted, 47 "Phase 2" clinical trials and 52 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".